Literature DB >> 9430372

Human beta-migrating very low density lipoprotein induces foam cell formation in human mesangial cells.

Y Anami1, S Kobori, M Sakai, M Kasho, T Nishikawa, T Yano, H Matsuda, T Matsumura, T Takemura, M Shichiri.   

Abstract

To elucidate the mechanism of foam cell formation in the mesangial region of a kidney observed in a familial type III hyperlipoproteinemic patient presenting with diabetes mellitus and nephrotic syndrome, we have examined, in the present study, the effect of human beta-VLDL (apo E2/E2) on foam cell formation in human mesangial cells, since an increase in beta-VLDL is a characteristic feature of this patient. Human beta-VLDL (apo E2/E2) induced foam cell formation in human mesangial cells. The binding of [125I]LDL to human mesangial cells was inhibited completely by both LDL and beta-VLDL. On the other hand, the binding of [125I]beta-VLDL was completely inhibited by beta-VLDL, but partially by LDL. The LDL receptor, but not the VLDL receptor was down-regulated by accumulation of cholesteryl esters. These results suggest that human beta-VLDL (apo E2/E2)-induced foam cell formation in mesangial cells is mediated through both the LDL receptor pathway and the beta-VLDL specific pathway, in which the VLDL receptor is one of the candidates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430372     DOI: 10.1016/s0021-9150(97)00166-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.

Authors:  T M E Davis; R Ting; J D Best; M W Donoghoe; P L Drury; D R Sullivan; A J Jenkins; R L O'Connell; M J Whiting; P P Glasziou; R J Simes; Y A Kesäniemi; V J Gebski; R S Scott; A C Keech
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

2.  Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.

Authors:  Eva Rohde; Katharina Schallmoser; Andreas Reinisch; Nicole A Hofmann; Thomas Pfeifer; Eleonore Fröhlich; Gerald Rechberger; Gerhard Lanzer; Dagmar Kratky; Dirk Strunk
Journal:  Cytotherapy       Date:  2010-12-03       Impact factor: 5.414

3.  Cellular cholesterol transport proteins in diabetic nephropathy.

Authors:  Joseph G S Tsun; Susan Yung; Mel K M Chau; Sammy W M Shiu; Tak Mao Chan; Kathryn C B Tan
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.